desipramine has been researched along with Respiration Disorders in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roux, JC | 1 |
| Villard, L | 1 |
1 other study available for desipramine and Respiration Disorders
| Article | Year |
|---|---|
[Pharmacological treatment of Rett syndrome improves breathing and survival in a mouse model].
Topics: Adrenergic Uptake Inhibitors; Animals; Brain Stem; Cells, Cultured; Desipramine; Drug Evaluation, Pr | 2007 |